Glucose tolerance and insulin resistance after danazol treatment

In: Journal of Obstetrics and Gynaecology · 1989 · vol. 9(3) , pp. 229–232 · doi:10.3109/01443618909151048 · W1997777644
Non-randomised trial OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

Danazol treatment in non-diabetic women with endometriosis resulted in impaired glucose tolerance and increased insulin response, likely due to its androgenic effects.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

SummarySummaryBlood glucose and serum insulin concentrations were measured during an oral glucose tolerance test in nine non-diabetic women before and 6 weeks alter starting treatment with danazol for pelvic endometriosis.Danazol induced a mild deterioration in glucose tolerance and a marked increase in the insulin response to glucose loading. Sex hormone binding globulin concentrations were reduced by 80 per cent but there was no change in total testosterone and oestradiol concentrations.These data confirm that danazol increases insulin resistance in non-diabetic women, probably as a result of its androgenic properties. Danazol treatment should probably be avoided in women with impaired glucose tolerance.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (28)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
unpaywall
last seen: 2026-10-10T06:25:47.132674+00:00
License: CC0 · commercial use OK